Israel Englander Deciphera Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $1.97 Million - $2.51 Million	144,846 Added 22.21%	797,100 $12.5 Million
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $4.09 Million - $6.69 Million	404,317 Added 163.07%	652,254 $10.5 Million
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $2.28 Million - $2.74 Million	171,572 Added 224.67%	247,937 $3.49 Million
Q1 2023 May 15, 2023	SELL	$14.26 - $22.1 $5.73 Million - $8.88 Million	-402,001 Reduced 84.04%	76,365 $1.18 Million
Q4 2022 Feb 14, 2023	SELL	$14.85 - $19.04 $7.02 Million - $9.01 Million	-472,953 Reduced 49.72%	478,366 $7.84 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $3.94 Million - $6.44 Million	318,383 Added 50.3%	951,319 $17.6 Million
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $515,972 - $791,799	56,638 Added 9.83%	632,936 $8.32 Million
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $1.81 Million - $2.93 Million	-263,461 Reduced 31.37%	576,298 $5.34 Million
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $3.85 Million - $18.6 Million	500,448 Added 147.49%	839,759 $8.2 Million
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $3.43 Million - $4.81 Million	129,546 Added 61.76%	339,311 $11.5 Million
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $4.16 Million - $6.09 Million	127,008 Added 153.47%	209,765 $7.68 Million
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $4.24 Million - $5.96 Million	-105,090 Reduced 55.94%	82,757 $3.71 Million
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $5.21 Million - $6.66 Million	100,630 Added 115.38%	187,847 $10.7 Million
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $3.42 Million - $4.55 Million	78,152 Added 862.13%	87,217 $4.47 Million
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $5.52 Million - $9.7 Million	-149,121 Reduced 94.27%	9,065 $541,000
Q1 2020 May 14, 2020	BUY	$33.63 - $69.4 $3.43 Million - $7.08 Million	101,992 Added 181.5%	158,186 $6.51 Million
Q4 2019 Feb 14, 2020	SELL	$31.7 - $69.93 $83.7 Million - $185 Million	-2,641,505 Reduced 97.92%	56,194 $3.5 Million
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $24.6 Million - $48 Million	1,234,342 Added 84.35%	2,697,699 $91.6 Million
Q2 2019 Aug 15, 2019	SELL	$21.05 - $26.21 $59.8 Million - $74.5 Million	-2,841,872 Reduced 66.01%	1,463,357 $33 Million
Q2 2019 Aug 14, 2019	BUY	$21.05 - $26.21 $64.2 Million - $79.9 Million	3,048,740 Added 242.64%	4,305,229 $245 Million
Q1 2019 May 14, 2019	BUY	$20.65 - $29.55 $203,381 - $291,037	9,849 Added 0.79%	1,256,489 $29.2 Million
Q4 2018 Feb 14, 2019	BUY	$19.08 - $36.14 $22.2 Million - $42.1 Million	1,163,815 Added 1405.15%	1,246,640 $26.2 Million
Q3 2018 Nov 14, 2018	BUY	$33.57 - $42.1 $1.86 Million - $2.34 Million	55,464 Added 202.71%	82,825 $3.21 Million
Q2 2018 Aug 14, 2018	SELL	$20.06 - $44.95 $4.29 Million - $9.61 Million	-213,700 Reduced 88.65%	27,361 $1.08 Million
Q1 2018 May 15, 2018	SELL	$20.04 - $29.71 $9.77 Million - $14.5 Million	-487,522 Reduced 66.91%	241,061 $4.83 Million
Q4 2017 Feb 14, 2018	BUY	$16.54 - $24.2 $667,422 - $976,518	40,352 Added 5.86%	728,583 $16.5 Million
Q3 2017 Nov 14, 2017	BUY	$17.65 - $18.99 $12.1 Million - $13.1 Million	688,231	688,231 $13.1 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account